Clinical Trial Update: Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2 [NA]

View source ↗

Summary

This clinical trial update from Stanford University investigates the links between obesity, insulin resistance, and post-acute sequelae of SARS-CoV-2 infection …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Stanford University | Conditions: Long COVID, Insulin Resistance | NA | Status: RECRUITING